Tag: HgCapital
‘Record fine imposed on hydrocortisone manufacturers for dominant position abuse and 10,000% price increase’
The Competition Appeal Tribunal (CAT) has upheld the Competition and Markets Authority’s (CMA) findings against two pharmaceutical manufacturers who consistently overcharged hydrocortisone tablets for...
Tribunal upholds £84 million fine on Advanz Pharma, PE firms over drug price inflation
Advanz Pharma, alongside London-based private equity firms Cinven and HgCapital, is collectively confronted with an £84 million penalty for inflating the price of the...